The new collaboration is based on an exclusive agreement to manufacture Naturamed’s innovative product line at Vitiva’s advance facilities and market the line to the US and Europe markets via Vitiva’s distribution channels.
Ohad Cohen, CEO of Vitiva, said: “We are extremely pleased with this new joint adventure with Naturamed. It will open new horizons for both companies and will help complete Vitiva’s food supplement portfolio. Our goal in this market is to develop innovative, yet traditional supplements for assisting to relief health acute problems.”
“The population of developed countries, including the West and Japan, is getting older while healthcare costs are increasing year by year,” explained Cohen. “The older population raises the demand for effective natural solutions for specific health conditions. Our goal is to offer the consumer natural remedies, backed by scientific research, for improving health.”
Naturamed is a biotech company that develops unique compounds extracted from specific strains of plant materials for improved natural treatment solutions. The company focuses especially on products directed toward ameliorating benign prostatic hyperplasia (BPH).
Vitiva is a fast-growing and innovative company providing advanced, application-specific solutions based on natural extracts for the food, cosmetic, pharmaceutical and nutraceutical industries.
Source: Vitiva
© FoodBev Media Ltd 2024